Journal
DRUG RESISTANCE UPDATES
Volume 6, Issue 4, Pages 183-195Publisher
CHURCHILL LIVINGSTONE
DOI: 10.1016/S1368-7646(03)00044-X
Keywords
p21(WAF1/Cip1); apoptosis; cell cycle; drug sensitivity; chemotherapy
Categories
Ask authors/readers for more resources
p21 (WAF1/Cip1) was initially identified as a cell cycle regulatory protein that can cause cell cycle arrest. It is induced by both p53-dependent and p53-independent mechanisms. This mini-review briefly discusses its currently known functions in apoptosis and drug sensitivity. As an inhibitor of cell proliferation, p21 (WAF1/Cip1) plays an important role in drug-induced tumor suppression. Nevertheless, a number of recent studies have shown that p21 (WAF1/Cip1) can assume both pro- or anti-apoptotic functions in response to anti-tumor agents depending on cell type and cellular context. This dual role of p21 (WAF1/Cip1) in cancer cells complicates using p21 (WAF1/Cip1) status to predict response to anti-tumor agents. However, it is possible to develop p21 (WAF1/Cip1) -targeted reagents or p21 (WAF1/Cip1) gene transfer techniques to have a beneficial effect within a well-defined therapeutic context. Better understanding of the roles of p21 (WAF1/Cip1) in tumors should enable a more rational approach to anti-tumor drug design and therapy. (C) 2003 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available